May 30, 2018 | Harriet Kozak, Intellus, Rachel Howard, USA, emerging markets
Earlier this month, US President Harriet Kozak and Emerging Markets Director Rachel Howard attended the inaugural Intellus Worldwide Summit in Philadelphia
The theme of the conference was ‘7 billion voices’, exploring how patient experiences, programs and health literacy can be improved through insights delivered by market researchers in the pharmaceutical industry.
As part of the keynote speeches, we were honored to hear the perspective of patient advocates and leaders in rare disease. Hearing directly from patients who had lived through unimaginably challenging experiences provided a humbling reminder and refocusing of our common goal as an industry – to ultimately improve patients’ lives.
Find out more: https://www.researchpartnership.com/news/2018/05/intellus-round-up-2018/
This content was provided by Inizio
Latest Content from Inizio
Our client wanted to identify the optimum selling price for their chronic disease treatment in emerging markets, based on patient’s willingness to pay for the product out of pocket.Find out…
Our latest white paper on immuno-oncology explores the challenges and opportunities in emerging markets, with a focus on Asia.
Pegasus received three top accolades at the PM Society Digital Media Awards 2016, including gold for the highly acclaimed Craft: Best Innovation award with Biogen’s MS Explorer, and two silvers…
We’ve built a new type of health communications consultancy. One that believes in a ‘health first, sector second’ approach. One that connects with every stakeholder. One that blends traditional, digital…
To reflect the importance of self-care in health, we developed and launched a new model for exploring personal health decision-making which provides a framework for strategic planning, whatever the therapy…
Telling a health message is one half of the battle. Ensuring that these messages resonate is another matter entirely. The Lab is our 25-strong, in-house creative and content team within…
Pegasus, the UK’s leading independent health communications consultancy, has had recognition of its work in digital media with shortlistings for four awards at the PM Society Digital Media Awards 2016…
Research findings from our Therapy HCV study shows that 28% of HCV patients in the EU are infected by sharing needles or drug equipment.Our latest market snapshot offers an introduction…
Published in eyeforpharma February 2016 by Rachel Howard
Often a short research study isn’t sufficient to get the level of insights and understanding that you require, especially when working with a hard to reach target audience.It can also…
